File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A retrospective analysis on the use of gemfibrozil in general outpatient clinics

TitleA retrospective analysis on the use of gemfibrozil in general outpatient clinics
Authors
KeywordsFibrates
Dyslipidaemia
Triglyceridaemia
Statins
Primary care
Gemfibrozil
Issue Date2005
Citation
Hong Kong Practitioner, 2005, v. 27, n. 11, p. 404-410 How to Cite?
AbstractObjective: To assess the current use of lipid lowering medication in general outpatient clinics (GOPCs) and explore the need for introduction of alternative modalities of treatment. Design: Retrospective analysis. Subjects: All patients prescribed with gemfibrozil in New Territories Cluster's GOPCs. Main outcome measures: Pre-treatment cardiovascular disease risk levels according to Joint British Societies cardiovascular disease risk charts, pre-treatment triglyceride (TG) levels. Results: 1157 patients were prescribed with gemfibrozil over the eight weeks of data collection. 15% did not have any pre-treatment TG levels. Only 13.1% fit pretreatment criteria for initiating gemfibrozil. 43% of those taking gemfibrozil have co-existing atherosclerotic disease or diabetes warranting the use of alternative lipid lowering therapy. On the one hand, the current daily cost of inappropriate prescription of gemfibrozil in these 1157 patients is HK$853. On the other hand, statins at a cost of HK$2.38 per dose would result in cost neutrality with an expected improvement in cardiovascular disease risk in the same group of patients. Conclusions: This study has highlighted the overuse of gemfibrozil for a population who may benefit from alternative therapy.
Persistent Identifierhttp://hdl.handle.net/10722/205697
ISSN
2015 SCImago Journal Rankings: 0.101

 

DC FieldValueLanguage
dc.contributor.authorKung, Kenny-
dc.contributor.authorLam, Augustine-
dc.contributor.authorLi, Philip-
dc.date.accessioned2014-10-06T08:02:13Z-
dc.date.available2014-10-06T08:02:13Z-
dc.date.issued2005-
dc.identifier.citationHong Kong Practitioner, 2005, v. 27, n. 11, p. 404-410-
dc.identifier.issn1027-3948-
dc.identifier.urihttp://hdl.handle.net/10722/205697-
dc.description.abstractObjective: To assess the current use of lipid lowering medication in general outpatient clinics (GOPCs) and explore the need for introduction of alternative modalities of treatment. Design: Retrospective analysis. Subjects: All patients prescribed with gemfibrozil in New Territories Cluster's GOPCs. Main outcome measures: Pre-treatment cardiovascular disease risk levels according to Joint British Societies cardiovascular disease risk charts, pre-treatment triglyceride (TG) levels. Results: 1157 patients were prescribed with gemfibrozil over the eight weeks of data collection. 15% did not have any pre-treatment TG levels. Only 13.1% fit pretreatment criteria for initiating gemfibrozil. 43% of those taking gemfibrozil have co-existing atherosclerotic disease or diabetes warranting the use of alternative lipid lowering therapy. On the one hand, the current daily cost of inappropriate prescription of gemfibrozil in these 1157 patients is HK$853. On the other hand, statins at a cost of HK$2.38 per dose would result in cost neutrality with an expected improvement in cardiovascular disease risk in the same group of patients. Conclusions: This study has highlighted the overuse of gemfibrozil for a population who may benefit from alternative therapy.-
dc.languageeng-
dc.relation.ispartofHong Kong Practitioner-
dc.subjectFibrates-
dc.subjectDyslipidaemia-
dc.subjectTriglyceridaemia-
dc.subjectStatins-
dc.subjectPrimary care-
dc.subjectGemfibrozil-
dc.titleA retrospective analysis on the use of gemfibrozil in general outpatient clinics-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.scopuseid_2-s2.0-31344457989-
dc.identifier.volume27-
dc.identifier.issue11-
dc.identifier.spage404-
dc.identifier.epage410-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats